Delivery Order 36C25625D0053-36C25626N0370
- Not listed
- Caredx, Inc., a medical technology company specializing in advanced diagnostic solutions for organ transplant patients, received a purchase order valued at $66,908.60 from the Veterans Integrated Service Network 17 (VISN 17) on December 15, 2023. The contract, which carries a firm fixed price structure with no set-aside designation, covers AlloSure kidney tests, AlloSure heart tests, and AlloMap heart tests. Performance is scheduled for completion by June 14, 2024, with services to be...
- This is a federal contract award to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $4,807,230.45, is for laboratory tests for post-transplant organ rejection and was awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 31, 2026....
- This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
- This federal contract award is for the provision of TRANSPLANT TESTING KITS by Caredx, Inc., a for-profit organization that specializes in advanced medical testing products and services to support organ transplant programs. The contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), has a ceiling value of $2,397,593.00 and is structured as a Delivery Order on a Firm Fixed Price basis. The contract does not have a set-aside...
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
- Caredx, Inc., a Brisbane, California-based medical technology company specializing in advanced diagnostic solutions for organ transplant patients, was awarded a delivery order valued at $142,037.50 by Veterans Integrated Service Network (VISN) 23 on January 15, 2026. The contract, which carries an ultimate completion date of January 14, 2028, is for AlloSure in-home patient testing services and operates under firm fixed pricing without a set-aside designation. The work will be performed in...
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
- This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $244,800.00, is for laboratory tests and specialty transplant services. The contract is not set aside and was awarded under the VA's Veterans Integrated Service Network 9 (VISN 9) to Caredx, which has been awarded multiple indefinite...
- CareDx, Inc., a medical technology company headquartered in Brisbane, California, received a delivery order award from the Department of Veterans Affairs Veterans Integrated Service Network 12 (VISN 12) on February 1, 2026, for transplant testing kits. This firm fixed-price delivery order has a ceiling value of $1.6 million with an ultimate completion date of January 31, 2027. The contract represents a continuation of the VA's reliance on CareDx's specialized diagnostic solutions for organ...
- 36C25625D0053Indefinite Delivery Contract
- 36C25625D0053-36C25626N0370Delivery Order
Caredx, Inc., a medical technology company specializing in advanced diagnostic solutions for transplant patients, was awarded a delivery order by Veterans Integrated Service Network (VISN) 16 on April 1, 2026, to provide laboratory testing services for post-transplant care. The firm fixed-price delivery order carries a ceiling value of $770,804.50 and extends through March 31, 2027. This award was not designated as a set-aside contract and will be performed in Houston, Texas. The contract supports the Department of Veterans Affairs' clinical operations through diagnostic testing that assesses organ rejection risks and monitors post-transplant patient outcomes for veteran beneficiaries. This delivery order is issued under Caredx's broader Indefinite Delivery Contract relationship with VISN 16, which includes a $4.37 million IDC awarded in April 2025 for lab tests for post-transplant care through March 2030. Caredx's core service offerings include AlloMap gene expression profiling tests and AlloSure kidney and heart diagnostic tests, which have become standard offerings across multiple VA regional networks. The company maintains an extensive federal contracting portfolio with the Department of Veterans Affairs across nine VISNs, supplemented by awards from the National Institutes of Health, Centers for Disease Control and Prevention, and the Navy Bureau of Medicine and Surgery, demonstrating sustained federal reliance on its proprietary transplant diagnostic capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $770.8k | 2/6/26 |